Epstein-Barr virus: the mastermind of immune chaos

被引:26
作者
Silva, Jean de Melo [1 ,2 ]
Alves, Carlos Eduardo de Castro [1 ]
Pontes, Gemilson Soares [1 ,2 ]
机构
[1] Natl Inst Amazonian Res INPA, Lab Virol & Immunol, Manaus, AM, Brazil
[2] Univ Fed Amazonas, Inst Biol Sci, Postgrad Program Basic & Appl Immunol, Manaus, AM, Brazil
关键词
EBV; herpesvirus; evasion; innate immunity; acquired immunity; NF-KAPPA-B; NATURAL-KILLER-CELLS; CLASS-II EXPRESSION; MEMBRANE-PROTEIN; GENE-EXPRESSION; DENDRITIC CELLS; NLRP3; INFLAMMASOME; BHRF1; PROTEIN; T-BET; EBV;
D O I
10.3389/fimmu.2024.1297994
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Epstein-Barr virus (EBV) is a ubiquitous human pathogen linked to various diseases, including infectious mononucleosis and multiple types of cancer. To control and eliminate EBV, the host's immune system deploys its most potent defenses, including pattern recognition receptors, Natural Killer cells, CD8+ and CD4+ T cells, among others. The interaction between EBV and the human immune system is complex and multifaceted. EBV employs a variety of strategies to evade detection and elimination by both the innate and adaptive immune systems. This demonstrates EBV's mastery of navigating the complexities of the immunological landscape. Further investigation into these complex mechanisms is imperative to advance the development of enhanced therapeutic approaches with heightened efficacy. This review provides a comprehensive overview of various mechanisms known to date, employed by the EBV to elude the immune response, while establishing enduring latent infections or instigate its lytic replication.
引用
收藏
页数:16
相关论文
共 188 条
[41]   EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy [J].
Fang, Wenfeng ;
Zhang, Jianwei ;
Hong, Shaodong ;
Zhan, Jianhua ;
Chen, Nan ;
Qin, Tao ;
Tang, Yanna ;
Zhang, Yaxiong ;
Kang, Shiyang ;
Zhou, Ting ;
Wu, Xuan ;
Liang, Wenhua ;
Hu, Zhihuang ;
Ma, Yuxiang ;
Zhao, Yuanyuan ;
Tian, Ying ;
Yang, Yunpeng ;
Xue, Cong ;
Yan, Yue ;
Hou, Xue ;
Huang, Peiyu ;
Huang, Yan ;
Zhao, Hongyun ;
Zhang, Li .
ONCOTARGET, 2014, 5 (23) :12189-12202
[42]   EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9 [J].
Fathallah, Ikbal ;
Parroche, Peggy ;
Gruffat, Henri ;
Zannetti, Claudia ;
Johansson, Hanna ;
Yue, Jiping ;
Manet, Evelyn ;
Tommasino, Massimo ;
Sylla, Bakary S. ;
Hasan, Uzma A. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (11) :6439-6447
[43]   EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins [J].
Fitzsimmons, Leah ;
Cartlidge, Rachel ;
Chang, Catherine ;
Sejic, Nenad ;
Galbraith, Laura C. A. ;
Suraweera, Chathura D. ;
Croom-Carter, Deborah ;
Dewson, Grant ;
Tierney, Rosemary J. ;
Bell, Andrew, I ;
Shannon-Lowe, Clare ;
Herold, Marco J. ;
Rickinson, Alan B. ;
Colman, Peter M. ;
Huang, David C. S. ;
Strasser, Andreas ;
Kvansakul, Marc ;
Rowe, Martin ;
Kelly, Gemma L. .
CELL DEATH AND DIFFERENTIATION, 2020, 27 (05) :1554-1568
[44]   The role of microRNAs in Epstein-Barr virus latency and lytic reactivation [J].
Forte, Eleonora ;
Luftig, Micah A. .
MICROBES AND INFECTION, 2011, 13 (14-15) :1156-1167
[45]   The Epstein-Barr Virus EBNA1 Protein [J].
Frappier, Lori .
SCIENTIFICA, 2012, 2012
[46]   Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections [J].
Gaglia, Marta Maria .
VIROLOGY JOURNAL, 2021, 18 (01)
[47]   AN EBNA-1-DEPENDENT ENHANCER ACTS FROM A DISTANCE OF 10-KILOBASE PAIRS TO INCREASE EXPRESSION OF THE EPSTEIN-BARR-VIRUS LMP GENE [J].
GAHN, TA ;
SUGDEN, B .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2633-2636
[48]  
Galperin C, 1994, Rev Hist Sci Paris, V47, P7, DOI 10.3406/rhs.1994.1189
[49]   EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation [J].
Gilardini Montani, Maria Saveria ;
Santarelli, R. ;
Granato, M. ;
Gonnella, R. ;
Torrisi, M. R. ;
Faggioni, A. ;
Cirone, M. .
AUTOPHAGY, 2019, 15 (04) :652-667
[50]   The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells [J].
Gram, Anna M. ;
Oosenbrug, Timo ;
Lindenbergh, Marthe F. S. ;
Bull, Christian ;
Comvalius, Anouskha ;
Dickson, Kathryn J. I. ;
Wiegant, Joop ;
Vrolijk, Hans ;
Lebbink, Robert Jan ;
Wolterbeek, Ron ;
Adema, Gosse J. ;
Griffioen, Marieke ;
Heemskerk, Mirjam H. M. ;
Tscharke, David C. ;
Hutt-Fletcher, Lindsey M. ;
Wiertz, Emmanuel J. H. J. ;
Hoeben, Rob C. ;
Ressing, Maaike E. .
PLOS PATHOGENS, 2016, 12 (04)